Showing results (11-20 of 5,280) with videos related to
Sort By:
Pageof 528
Anti-Cancer Agents in Medicinal Chemistry|November 29, 2022
Novel 1,4-Dihydropyrido[2,3-B]Pyrazine-2,3-Dione Derivatives for Treating Cancer and Other Disorders Associated with KRAS ActivitySurya K DeNederlands Tijdschrift Voor Geneeskunde|April 10, 2002
[Karl Landsteiner (1868-1943) and the specificity of serological reactions, one hundred years ago and now]K de MeerInternational Journal of Palliative Nursing|March 30, 2002
Enhancing creativity to improve palliative care: the role of an experiental self-care workshopK de VriesJournal of Virological Methods|March 20, 1998
Reduction of singleton reactors against swine vesicular disease virus by a combination of virus neutralisation test, monoclonal antibody-based competitive ELISA and isotype specific ELISAK De ClercqCurrent Medicinal Chemistry|February 16, 2023
Abrocitinib: First Globally Approved Selective Janus Kinase-1 Inhibitor for the Treatment of Atopic DermatitisSurya K DeEndocrine, Metabolic & Immune Disorders Drug Targets|February 21, 2023
Novel 2,4- diaminopyrimidine 5-carboxamides as c-Jun N-terminal Kinase Inhibitors for Treating the Liver Fibrotic DisorderSurya K DeCurrent Medicinal Chemistry|March 24, 2023
Ganaxolone: First FDA-approved Medicine for the Treatment of Seizures Associated with Cyclin-dependent Kinase-like 5 Deficiency DisorderSurya K DeCurrent Medicinal Chemistry|May 26, 2023
Pyrazolo[4,3-H]quinazolines as Cyclin-dependent Kinase Inhibitors for Treating CancerSurya K DeCurrent Medicinal Chemistry|October 11, 2023
Pirtobrutinib: First Non-covalent Tyrosine Kinase Inhibitor for Treating Relapsed or Refractory Mantle Cell Lymphoma in AdultsSurya K DePageof 528